250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Device Startup Investors in United States

A list of 50 angel investors and VC funds that invest in Medical device startups based in United states. We rank investors based on the number of investments they made in Medical device companies from United states. We update this investor list every month.

Top 50 Medical Device Startup Investors in United States

Investor Medical Device United States investments
Innova Memphis 71
Portfolia 20
Broadview Ventures 19
CincyTech 18
HealthTech Capital 18
Good Growth Capital 16
MB Venture Partners 16
North Coast Ventures 16
Oxford Finance LLC 15
Boston Harbor Angels 15
TEDCO 15
Maine Angels 15
Texas HALO Fund 15
Arboretum Ventures 14
Wavemaker 360 14
New Enterprise Associates 14
Connecticut Innovations 14
Horizon Technology Finance 13
Oxford Bioscience Partners 13
U.S. Venture Partners 13
Ben Franklin Technology Partners of Southeastern Pennsylvania 13
Khosla Ventures 13
Catalyst Health Ventures 12
Sand Hill Angels 12
Versant Ventures 12
Wisconsin Investment Partners 12
Delphi Ventures 12
Canaan Partners 12
Catalyst Health Ventures 12
Kleiner Perkins 11
Houston Angel Network 11
Split Rock Partners 11
Gaingels 11
Tech Coast Angels 11
Sante Ventures 10
Silicon Valley Bank 10
Rev1 Ventures 10
DeNovo Ventures 10
Shangbay Capital 10
Three Arch Partners 10
Virginia Venture Partners 10
Green Park & Golf Ventures 10
Third Rock Ventures 10
Morgenthaler Ventures 10
St. Louis Arch Angels 10
Life Science Angels 10
Keiretsu Capital 10
Square 1 Bank 9
Golden Seeds 9
Launch NY 9
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Innova Memphis VC Fund · Memphis, Tennessee, United States · 2 investments in the past 12 months
Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Pre-Seed, Convertible Note
  • United States, Argentina, United Kingdom
Portfolio highlights
  • Rantizo — Fly more acres, deliver better service. The equipment, tools, and expertise you need to be the grower's first call for drone spray services.
  • iYOTAH Solutions — iYOTAH Solutions is a transformational SaaS technology company that connects data to help the animal protein industry thrive.
  • Glanris — Glanris developed a completely green, non-toxic, filtration media for water purification from an agriculture by-product. This agricultural product is grown around the world, is plentiful, and can be used locally to ensure clean drinking water in developing countries. It also gives local farmers a significant additional income source for a productthat today they are throwing away.This media has been independently tested over the last two years of development and is ready for production.
Portfolia VC Fund · San Mateo, California, United States · 2 investments in the past 12 months
Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Seed, Series A, Series B
  • United States, Canada, Argentina
Portfolio highlights
  • Attn: Grace — Attn: Grace is a sustainable wellness brand designed for women. Starting with bladder leakage, they're creating thoughtful, more sustainable solutions for life’s inconvenient truths, one challenge at a time.
  • Prime Roots — Prime Roots is on a mission to provide a better cut of meat for every type of eater. Rooted in koji, Prime Roots is able to replicate the taste and texture of meat without any of the environmental costs of animal proteins.
  • Harvest Thermal — We are manufacturers of the cleanest home energy solution on the market today. We offer a cloud-enabled, ultra-clean heating, cooling and hot water system for residential customers. The brains of the system is our award-winning Harvest Pod that slashes carbon emissions, saves on utility bills, and
Broadview Ventures VC Fund · Boston, Massachusetts, United States
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Seed, Debt Financing
  • United States, Canada, Israel
Portfolio highlights
  • IsomAb — IsomAb evaluate and develop isoform specific antibodies to treat disease.
  • Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
  • Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
CincyTech VC Fund · Cincinnati, Ohio, United States
CincyTech is one of the Midwest's most active seed funds, investing in disruptive human health and technology companies in Ohio.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Series A, Series B
  • United States
Portfolio highlights
  • Amify — We help brands selling on Amazon maximize sales and profitability by providing complete strategy, management and operational services.
  • Invirsa — Invirsa is developing a unique, broad platform based on a naturally occurring small molecule (INV-102) that has demonstrated enhanced immune response to infection. INV-102 not only reduces viral infection, and potentially bacterial replication, it also reduces inflammation, while enhancing the bodies wound healing response. Invirsa'stechnology is first being developed in the ophthalmology and pulmonary space.Invirsa’s technology has the potential to be a first line therapy for common infectious diseases, whether it's the 100 million viral pulmonary infections or the 5 million infectious conjunctivitis cases that occur every year in the US alone.
  • Voxel — Voxel utilizes advanced mathematics and artificial intelligence to rapidly generate functionally graded meta-materials for high performance applications through additive manufacturing. We provides performance leaps in the defence, automotive, aerospace, medical, industrial, and other demanding areas and unlock new capabilities for our customers.
HealthTech Capital VC Fund · Los Altos Hills, California, United States
Private angel investors and corporate venture ecosystem investing in healthtech, digital health and other healthcare technologies startups
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Seed, Series A, Convertible Note
  • United States
Portfolio highlights
  • SafKan Health — OtoSet® by SafKan Health is the first FDA Cleared automated ear cleaning device for the 35 million Americans affected by impacted earwax - the leading cause of conductive hearing loss.
  • GT Metabolic Solutions — GT Metabolic Solutions has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery.
  • Wavely Diagnostics — Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.
Good Growth Capital VC Fund · Charleston, South Carolina, United States · 8 investments in the past 12 months
Good Growth Capital is an early-stage venture capital firm known for its expertise in finding, assessing and cultivating complex science and technology.
Show more
Investment focus
  • Health Care, Information Technology, Software
  • Seed, Series A, Convertible Note
  • United States, France, Israel
Portfolio highlights
  • Pienso — Use Machine Learning to explore language data without a single line of code. Experiment, train and deploy effortlessly, with an interactive and responsive learning interface that imprints your expertise at AI scale.
  • Next Power 360 — NextPower360 offers the most advanced generator in the world for variable input and output applications such as wind power and electric vehicles.
  • Base Operations — Base Operations aggregates and visualizes threat data to help companies keep their people and operations safe around the world.
MB Venture Partners VC Fund · Memphis, Tennessee, United States
MB Venture Partners in Memphis, TN provides venture capital for life sciences: medical device, biotechnology companies, products for musculoskeletal diseases
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Series B, Series C
  • United States, Israel
Portfolio highlights
  • Cast21 — The future of orthopedic technology has arrived. Cast21 braces are designed for your active lifestyle.
  • SweetBio — SweetBio is a Memphis, Tennessee based medical device company specializing in bioengineering honey-incorporated materials for wound care.
  • Lineus Medical — Lineus Medical is a medical device company focused on reducing IV complications for patients and providers all over the world.
North Coast Ventures VC Fund · Cleveland, Ohio, United States · 5 investments in the past 12 months
North Coast Ventures (formerly North Coast Angel Fund) is comprised of four contributed capital funds with a focus on early-stage technology investments. Our membership consists of a number of Ohio's leading investors, entrepreneurs, and business leaders who are dedicated to accelerating early-stage ventures.North Coast Ventures members playan active role by generating deal flow, serving on due diligence teams, working with portfolio companies, or serving on the Investment Screening and Executive Committees. Through this involvement, our goal is to provide a supportive environment for our portfolio companies and ultimately enhance the performance of our Fund.Northeast Ohio has a long tradition of active and successful angel investing, but until recently, the success of this crucial form of funding has hinged on the efforts of a relatively small number of individual investors. As the region’s first professionally managed angel fund, North Coast Angel Fund works to improve the early-stage funding environment for both entrepreneurs and investors.
Show more
Investment focus
  • Health Care, Software, Medical Device
  • Series A, Seed, Funding Round
  • United States
Portfolio highlights
  • Narratize — Our generative AI software helps innovative enterprises quickly produce impactful, accurate, compelling communications and deliverables by distilling their ideas and expertise.
  • Redi.Health — Redi.Health is a healthcare technology company that develops health management platforms for patients. The company aims to connect patients with chronic diseases to patient support programs. These programs are created in partnership with pharmaceutical manufacturers and are always free to the patient.
  • BetterYou — BetterYou is a digital wellness platform that helps to make better health and wellness decisions every day. The platform leverages the data exhaust created from using their devices every single day to create insight around where people spend their time vs. what's actually important to them. Their users define what “time better spent” lookslike, and to help them stay on track.BetterYou provides population-level insights back to organizations, helping them drive health savings downstream by improving their employees’ digital and overall wellness. It also allows individuals to maximize their time and stay focused on goals that matter.
Oxford Finance LLC VC Fund · Alexandria, Virginia, United States
Providing Flexible and Creative Financial Solutions to Life Sciences and Healthcare Services Companies.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Debt Financing, Post-IPO Debt, Series B
  • United States, United Kingdom, Canada
Portfolio highlights
  • Amino — Amino's digital healthcare guidance platform provides a fast, easy way to find a doctor, book appointments, and access health benefits.
  • Headspace — Live a healthier, happier, more well-rested life in just a few minutes a day with the Headspace app.
  • Pearl Street Dental Management — Pearl Street Dental Management supports non-clinical operations. They provide centralized services such as human resources, payroll, accounting, bookkeeping, finance, lending, facilities management, and information technology services. They address inquiries through online applications, phone calls, and emails.
Boston Harbor Angels VC Fund · Boston, Massachusetts, United States
Boston Harbor Angels is a group of proven business leaders interested in investing a portion of their assets in high growth, early stage companies. The group was formed in February 2004 and since then has made a number of investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation,etc. They believe they contribute more than money to the companies they fund and welcome the opportunity to work with entrepreneurs open to take advice, yet having the smarts and determination to make the company successful.Their focus is on early stage companies usually looking to raise $250K to $1.5M, where they can fund a portion of the round and syndicate the deal with other angel groups or early stage venture funds. The stage of the company should be close to commercialization, while the company should have a clear and defensible competitive advantage. They are looking for capital efficient businesses, which can reach profitability with less than $5M of equity investment and provide at least 10X return on the investment within 5 years.They do not invest as a fund - each of their members makes his or her individual investment decision but they collaborate in Due Diligence. They have a deep expertise in the life sciences field where they usually take the position of a lead investor, but are open to any opportunities that can make a strong business case. In some cases they prefer to be the follow on investor if they cannot identify a person with strong expertise within their group.The group’s strategy is directed by an executive committee which consists of 8 people elected by the group: Wayne Griffith (chairman), Bill McPhee, Henry Kay, Jay Schwartz (membership director), Steve Andress, Peter Miller, Don Freeman and Mic Williams (president and founder). The group’s day-to-day operations are managed by Boris Batchvarov (managing director).They receive 20-30 business summaries each month, out of which they select 8 companies to make a personal presentation to their screening committee. The screening committee consists of volunteers from the group. The presentations are 10 min long followed by 10 min Q&A. 4 of the companies are invited to present to the whole group, with the idea to get the people interested and decide to perform a Due Diligence with the companies before making an investment.
Show more
Investment focus
  • Biotechnology, Health Care, Medical Device
  • Angel, Seed, Series A
  • United States, Canada, India
Portfolio highlights
  • Zylö Therapeutics — Patented technology that enables, for topicals, sustained release, increased druggability, a Patchless Patch concept, and enhanced targeting of pores and follicles
  • Xeno Biosciences — Xeno Biosciences operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery.It wasfounded in 2015 and is headquartered in Somerville, Massachusetts.
  • Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
TEDCO VC Fund · Columbia, Maryland, United States · 15 investments in the past 12 months
TEDCO was created by the Maryland State Legislature in 1998 to facilitate the transfer and commercialization of technology from Maryland’s research universities and federal labs into the marketplace and to assist in the creation and growth of technology-based businesses in all regions of the State. TEDCO is an independent organization thatstrives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy. In Maryland and beyond, TEDCO is a resource of mentoring, funding and networking for entrepreneurs and start-ups that need guidance as they bring innovative concepts to market. TEDCO is more than an early stage funding resource. It is the hub of Maryland’s entrepreneurial network where startups find mentors, organizational assistance, facilities for daily operations, and a roadmap for success.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Pre-Seed, Grant
  • United States
Portfolio highlights
  • ReBokeh — ReBokeh is a mobile application that offers visually impaired video filters to enhance the users' vision.
  • PediaMetrix — Founded by alumni entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford, PediaMetrix’s mission is to bring AI and computer vision to pediatrics to lower the healthcare costs and improve outcomes. PediaMetrix’s lead product, SoftSpot, enables early detection and management of the most common conditions with head shape abnormalities innewborns. PediaMetrix is a Delaware company founded in 2018.
  • Escalate USA — At Escalate, we solve the talent crisis for retail corporations. We increase employee retention and the internal pool of skilled middle-wage candidates by providing frontline workers with weekly asynchronous online training that leads to industry-recognized certifications and upward mobility.
Maine Angels VC Fund · Portland, Maine, United States
Maine Angels they make investments with entrepreneurs with an emphasis on businesses.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Angel
  • United States
Portfolio highlights
  • HighByte — HighByte is an industrial software development company in Portland, Maine building solutions that address the data architecture and security challenges created by Industry 4.0.
  • TOP the organic project — 100% Organic Cotton Period Care. Organic Tampons, Pads, First Period Kit & Bulk Period Products. Women-owned, eco-friendly, plant-based and sustainable. With every subscription, TOP gives back to women in need.
  • Pumpspotting — connect over breastfeeding, milk, motherhood, and the best places to nurse and pump. nurse, pump, nourish, connect.
Texas HALO Fund VC Fund · Houston, Texas, United States
Early Stage Venture Investments
Show more
Investment focus
  • Health Care, Medical Device, Software
  • Seed, Convertible Note, Series A
  • United States, Canada, Hungary
Portfolio highlights
  • Flourish Collective — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
  • Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
  • Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.
Arboretum Ventures VC Fund · Ann Arbor, Michigan, United States · 3 investments in the past 12 months
For over 20 years we have been a successful healthcare venture capital firm rooted in the Midwest. Check out our portfolio companies.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • United States, Canada
Portfolio highlights
  • Avation Medical — Avation Medical is pioneering new platforms for wearable nerve stimulation systems. They believe empowering patients to be in control of their therapies will allow for more personalized and custom care. That's why at Avation Medical, they are re‑imagining neuromodulation by developing patient‑centric solutions based on powerful, proven, smarttechnologies.Avation Medical transforms the neuromodulation market to elevate care for patients with chronic conditions.
  • Reprieve Cardiovascular — Reprieve Cardiovascular is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients.
  • Virtual Incision — Virtual Incision is reimagining robotic support for minimally invasive (MIS) procedures with simple innovations offering mobility, flexibility, and accessibility to provide MIS options to more patients. It has develops the MIRA® (Miniaturized In vivo Robotic Assistant) Platform, a first-of-its-kind miniaturized surgical robotic support device,focusing first on colon resection, with follow-on specialty robots for additional potential applications.
Wavemaker 360 VC Fund · Pasadena, California, United States · 5 investments in the past 12 months
Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Series A, Funding Round
  • United States, United Kingdom, Canada
Portfolio highlights
  • Elektra Health — Evidence-based menopause expertise & care because you deserve better
  • Pear Bio — Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.
  • Nest Collaborative — Nest Collaborative offers online lactation consults. Virtual appointments are available same-day & are covered in full by most insurance plans.
New Enterprise Associates VC Fund · Menlo Park, California, United States · 44 investments in the past 12 months
Foundational partners to ambitious founders at every stage of company-building.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series B, Series A, Series C
  • United States, India, China
Portfolio highlights
  • Faircado — Stop wasting time and money - faircado helps you find the best pre-owned deals for your wallet and the planet.
  • Twelve Labs — Twelve Labs helps developers make programs that can see, listen, and understand the world as we do by giving them the most powerful video search API
  • Amber Therapeutics — Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology
Connecticut Innovations VC Fund · Rocky Hill, Connecticut, United States · 13 investments in the past 12 months
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Funding Round
  • United States, Israel, Canada
Portfolio highlights
  • Conduce Health — Conduce Health is a multi-specialty value-based care marketplace providing turnkey solutions for primary care organizations.
  • DeepLook Medical — Enhancing Medical Imaging with Revolutionary Software: DeepLook Medical envisions a future where data-driven imaging enables accurate, efficient, and personalized care across the entire treatment pathway.
  • Manifest Technologies — Manifest Technologies advances AI-powered computational neuroimaging system that quantifies neural and symptom data.
Horizon Technology Finance VC Fund · Farmington, Connecticut, United States
Horizon is a venture lending platform that offers structured debt products to life science and technology companies. Its team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have, collectively, originated and invested more than $5 billionin venture loans to thousands of companies.The company was founded in 2003 and is headquartered in Farmington, Connecticut.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Debt Financing, Post-IPO Debt, Funding Round
  • United States, Canada, India
Portfolio highlights
  • Unagi Scooters — Unagi is an electric scooter startup that aims to liberate people from the tyranny of transportation frustrations—the costs, inconveniences, the carbon emissions. So we built the ideal personal liberation device.
  • Evelo Biosciences — Evelo Biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines – monoclonal microbials. Monoclonal microbials are orally delivered medicines that modulate systemic immunology and biology through direct interactions with human cells in the gut. These new medicines are broadlyapplicable across many diseases – including autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory diseases and cancer. Monoclonal microbials have the potential to fundamentally change traditional models of drug discovery and development. By finding and selecting naturally occurring monoclonal microbials with defined therapeutic effects, Evelo can improve the speed, cost and success of drug discovery and development. Evelo’s platform enables pharmacological intervention at all stages of disease with naturally occurring, safe and effective monoclonal microbials. Evelo Biosciences was conceived and created within VentureLabs®, Flagship Pioneering’s institutional innovation foundry, and launched by Flagship in 2015.
  • Viken Detection — Viken Detection is a research and technology development company focusing on X-ray physics and the design of analytical devices. The company's devices provide security imaging and material identification, which help to protect the public from terrorism and other dangerous dangers, allowing law enforcement and safety inspection agencies toremain vigilant and avoid drug trafficking.Viken was founded in 2013 and is headquartered in Newton, Massachusetts, United States.
Oxford Bioscience Partners VC Fund · Boston, Massachusetts, United States
Bigslot288 merupakan situs slot server thailand yang memerikan bocoran rtp tertinggi setiap hari gampang menang, Bigslot288 menerima deposit pulsa tanpa potongan
Show more
Investment focus
  • Health Care, Biotechnology, Pharmaceutical
  • Series B, Series C, Series A
  • United States, Germany, Switzerland
Portfolio highlights
  • Paperspace — Ceres, Inc. (Ceres) is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks. The Company’s large-scale commercial products are sweet sorghum varieties that can be used as a drop-in feedstock to extend the operating season of Brazilian sugarcane-to-ethanol mills. Its products include sweet sorghum, high biomasssorghum, switchgrass, miscanthus and row crops. Its energy crops can also be used for the production of second-generation biofuels and bio-based chemicals, including cellulosic ethanol, butanol, jet fuel, diesel-like molecules and gasoline-like molecules, from non-food biomass. Baseload utility scale electric power can also be generated from the biomass feedstocks grown from its seeds. Ceres has sold switchgrass and high biomass sorghum seeds in the United States under its Blade Energy Crops (Blade) brand. In January 2010, the Company incorporated a subsidiary, Ceres Sementes do Brasil Ltda.
  • CardioFocus — CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, andinvestigating disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of cardiac arrhythmias.CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.
  • Yolia Health — Yolia Health developed The True Vision Treatment or TVT, the 'Invisalign' for the eyes. A non-invasive treatment to correct vision problems like presbyopia without surgery. TVT is self-administered by the patient in his or her own home. It employs a combination of customized contact lenses (TVT Contacts) and specially formulatedeye drops (TVT Eye Drops). After only 5 days of treatment with TVT patients are able to stop using the TVT Contacts, TVT Eye Drops and their reading glasses for up to 12 months at a time before re-treatment with TVT is needed. What is even greater than correcting for presbyopia non-invasively, is correcting both eyes without compromising any distance vision. On the contrary, Yolia's treatment improves both near and distance vision, a unique feature no single other alternative can provide. ** Looking for sophisticated investors and key industry partners.
U.S. Venture Partners VC Fund · Menlo Park, California, United States · 10 investments in the past 12 months
U.S. Venture Partners (USVP) is a venture capital partnership, helping entrepreneurs transform their ideas and efforts into world-changing companies. The firm focuses on early-stage ventures in information technology and health care, where innovation is unbridled and has led to the creation of economic wealth and millions of jobs over the pastthirty-plus years of the firm's existence. Areas of particular interest to our investment professionals include enterprise software, IT security, consumer internet, mobile, and e-commerce, healthcare, and IT-enabled healthcare services. The USVP team consists of former entrepreneurs, technologists, corporate executives, financial professionals, and industry domain experts.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Series B, Series C, Series A
  • United States, Israel, Canada
Portfolio highlights
  • IONIX — IONIX helps you secure your organization with our cutting-edge attack surface management solutions. Protect your digital assets and minimize risk exposure today.
  • Cagent Vascular — Cagent Vascular Inc. is a developer of next generation angioplasty balloons using Serration Technology for the treatment of cardiovascular disease.
  • Sparrow Pharmaceuticals — Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of corticosteroid excess.
Ben Franklin Technology Partners of Southeastern Pennsylvania VC Fund · Philadelphia, Pennsylvania, United States · 3 investments in the past 12 months
We’re (not just) investors.We’re (more than) advisors.We’re (beyond) connectors.Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose – to lead the region’s technology community to new heights, creating jobs and transforming lives. For over 30 years, Ben has been the leading seedstage capital provider for the region’s technology sectors, investing over $170 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Grant, Debt Financing
  • United States
Portfolio highlights
  • GrowFlux — GrowFlux, Inc. they offers a ecosystem of commercial scale wireless lighting controls, cloud services, and cloud connected agricultural sensors.
  • SFA Therapeutics — SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs.
  • Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
Khosla Ventures VC Fund · Menlo Park, California, United States · 81 investments in the past 12 months
Khosla Ventures invests in companies that are bold, early and impactful. The firm was started in 2004 by Vinod Khosla, co-founder of Sun Microsystems, to provide venture assistance to entrepreneurs. Headquartered in Menlo Park, Calif., Khosla Ventures invests in a range of areas including AI, climate, sustainability, enterprise, consumer, fintech,digital health, medtech and diagnostics, therapeutics and frontier technology.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Series A, Series B, Seed
  • United States, India, United Kingdom
Portfolio highlights
  • WindBorne Systems — WindBorne designs, builds, and operates a constellation of long-duration smart weather balloons targeting the most critical data in the atmosphere.
  • Honey Homes — Hassle-free Home Upkeep
  • Cartwheel — Cartwheel is a powerful text-to-animation platform. Type animate characters for video, game, app, ad, social, AR, or VR projects simply. It builds to help tell stories faster, and more creatively.
Catalyst Health Ventures VC Fund · Braintree, Massachusetts, United States
Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of this strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Their disciplined investment process leverages bothintellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. We seek to invest in companies addressing major global unmet clinical needs in areas such as oncology, cardiovascular disease, obesity, and women’s health. We invest in pioneering and proprietary technological solutions fundamentally designed to reduce treatment costs and improve patient outcomes. By investing in solutions which have a technological foundation of engineering and development such as medical devices, diagnostic tools and instrumentation and consumer healthcare, we minimize the risks related to uncertain scientific experimentation.
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Series A, Series B, Series C
  • United States
Portfolio highlights
  • Epitel — Epilog is an unobtrusive wearable seizure detection system that records long-term EEG, anywhere. It gives people living with epilepsy peace of mind with a much-needed tool to better understand and manage their seizures.
  • Avive Solutions — Check out Avive Solutions, the manufacturers of a brand new AED machine - portable defibrillator - that's FDA approved!
  • PanTher Therapeutics — PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatmentat the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
Sand Hill Angels VC Fund · Mountain View, California, United States · 2 investments in the past 12 months
For over two decades, Sand Hill Angels has worked openly and collaboratively with venture capital funds, other angel organizations, and the Bay Area ecosystem that fosters the growth of technology startups.
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Seed, Series B, Series A
  • United States, Canada, Japan
Portfolio highlights
  • Pulzaid — Platform for hybrid specialty care
  • GaeaStar — The zero waste clay cup. GaeaStar is an engineering company developing sustainable multiple use products and technology.
  • PrivacyHawk — PrivacyHawk is a Personal Data Protection service that makes opting out, unsubscribing, and deleting your data from thousands of companies easy.
Versant Ventures VC Fund · Menlo Park, California, United States · 7 investments in the past 12 months
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Switzerland, Canada
Portfolio highlights
  • Firefly Bio — Firefly specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
  • SixPeaks Bio — SixPeaks is developing a pipeline of medicines for healthy weight loss.
  • Enterprise Therapeutics — Enterprise Therapeutics is a drug discovery company dedicated to the researchand development of novel therapies for the treatment of respiratory diseases.In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlyingmechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
Wisconsin Investment Partners VC Fund · Madison, Wisconsin, United States · 2 investments in the past 12 months
Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members. Membership has grown to 50+ members in recent years, bringing significant knowledge and experience.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Funding Round, Seed, Series A
  • United States, Canada, United Kingdom
Portfolio highlights
  • Flyte — Flyte promotes cellular healing in pelvic floor muscles for lasting results. Flyte is fast, proven, safe, pelvic floor therapy for bladder control.
  • BeeReaders — ## Build Setup
  • Midwest Games — Midwest Games is a video game publisher focused on creating opportunities for the abundant talent across the Midwest and other underrepresented regions.
Delphi Ventures VC Fund · San Mateo, California, United States · 4 investments in the past 12 months
Delphi Ventures leverages years of experience, passion, & expertise to advance new technologies and build market leading biotechnology companies.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series C, Series B, Series D
  • United States, Canada, Denmark
Portfolio highlights
  • MyShell — MyShell is a decentralized and comprehensive platform for discovering, creating, and staking AI-native apps.
  • Pixelmon — Collect, Evolve & Battle alongside your Pixelmon in our Multiplayer Open World Adventure and Monster Combat Arena.
  • Arrow Markets — The next generation of options markets. The Arrow protocol democratizes options trading through a hybrid RFQ system with on-chain exchange and settlement.
Canaan Partners VC Fund · Menlo Park, California, United States · 19 investments in the past 12 months
Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Series A, Series B, Series C
  • United States, United Kingdom, Israel
Portfolio highlights
  • Truveris — Truveris is a leading digital health company focused on delivering truth and clarity in pharmacy.
  • Reibus — Reibus is the leading platform for buying and selling steel and other metals, with end-to-end services including logistics and financing.
  • Grey Wolf Therapeutics — By targeting the ERAP proteases in the antigen presentation pathway Grey Wolf aims to change the antigen repertoire in cancer.
Catalyst Health Ventures VC Fund · Braintree, Massachusetts, United States · 2 investments in the past 12 months
Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of this strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Their disciplined investment process leverages bothintellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. We seek to invest in companies addressing major global unmet clinical needs in areas such as oncology, cardiovascular disease, obesity, and women’s health. We invest in pioneering and proprietary technological solutions fundamentally designed to reduce treatment costs and improve patient outcomes. By investing in solutions which have a technological foundation of engineering and development such as medical devices, diagnostic tools and instrumentation and consumer healthcare, we minimize the risks related to uncertain scientific experimentation.
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Series B, Series A, Series C
  • United States
Portfolio highlights
  • Rejoni — Learn about a clinical trial that is evaluating a new product which may prevent them.
  • Instylla — Instylla delivers next-generation liquid embolics for interventional radiology, with initial clinical applications in interventional oncology and peripheral hemostasis.
  • Brixton Biosciences — Brixton Biosciences is a biotechnology company currently operating in stealth mode.
Kleiner Perkins VC Fund · Menlo Park, California, United States · 31 investments in the past 12 months
Kleiner Perkins is an American venture capital firm headquartered on Sand Hill Road in Menlo Park in Silicon Valley.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Series B, Series A, Series C
  • United States, China, United Kingdom
Portfolio highlights
  • Alkira — The Alkira Cloud Network as-a-Service delivers enterprise networks in the cloud. No hardware to invest in, no software to configure and no cloud architecture to learn.
  • Fizz — Fizz, the student debit card that builds credit. Build your credit while you earn amazing rewards! No hidden fees, no credit check & no security deposit.
  • Browserbase — Browserbase is a comprehensive platform for developers to host, administer, and monitor headless browsers in the cloud.
Houston Angel Network VC Fund · Houston, Texas, United States
The Houston Angel Network (HAN) is a nonprofit organization dedicated to developing the innovation ecosystem in Houston, Texas by supporting founders and startups with financial resources and mentorship.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Funding Round, Series A
  • United States, Canada, United Kingdom
Portfolio highlights
  • CaseCTRL — Schedule surgeries with ease using AI-powered surgical scheduling. Fewer canceled cases, conflicts, and misorders. More surgery and time for patients!
  • Materna Medical — Materna Medical empowers women to protect and restore their pelvic health.
  • Amplified Sciences — Providing innovative diagnostic tests that enable earlier detection, risk stratification and monitoring of challenging diseases.
Split Rock Partners VC Fund · Minneapolis, Minnesota, United States
Split Rock Partners invests in emerging healthcare, software and Internet services companies in the Upper Midwest and West Coast. They are an early-stage venture capital firm that was founded in June 2004 by the former healthcare and software investment teams of St. Paul Venture Capital (SPVC). The Split Rock team managed over $1 billion of venturecapital during our tenure at SPVC, and continues to manage the SPVC healthcare and software portfolio. In May of 2008, they raised $300 million in the second Split Rock Partners fund, the successor to their inaugural $275 million fund raised in April 2005.The Split Rock team believes that it takes great people to translate promising ideas into compelling businesses. They are grounded in a fundamental respect for entrepreneurs and the rare combination of elements required when pioneering new markets. They start by looking for entrepreneurs with the passion, vision, and skills to build leading companies. They then work with entrepreneurs collaboratively, building partnerships based on integrity and mutual respect. The Split Rock team complements management expertise with over 80 years of venture investing and entrepreneurial management experience. They are proud of the strong relationships they have built with talented entrepreneurs and co-investors throughout their history and look forward to building on that tradition.
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Series A, Series B, Series C
  • United States, France
Portfolio highlights
  • Gravia — More benefits. Fewer asterisks. We are a health benefits company on a mission to build a health plan that everyone can love.
  • EBR Systems — EBR aims for outstanding treatment of cardiac rhythm diseases with an innovative leadless therapy.
  • Gravie — More benefits. Fewer asterisks. We are a health benefits company on a mission to build a health plan that everyone can love.
Gaingels VC Fund · New York, New York, United States · 73 investments in the past 12 months
Gaingels is a leading venture investment syndicate in support of diversity, inclusive of the LGBTQIA+ community and allies in the venture capital space.
Show more
Investment focus
  • Software, Health Care, FinTech
  • Seed, Series A, Series B
  • United States, Canada, Mexico
Portfolio highlights
  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Colors AI — Colors helps companies see the full spectrum of clients.
  • Novel Capital — Novel Capital provides non dilutive funding and operational sales expertise to early-stage B2B software companies.
Tech Coast Angels VC Fund · Newport Beach, California, United States · 2 investments in the past 12 months
Tech Coast Angels is the largest angel investor group in the United States, possessing more than 300 members in five networks in Los Angeles, Orange County, San Diego, Central Coast, and the Inland Empire. Its members provide funding and guidance to more early-stage, high-growth companies in Southern California than any other investment group.Members invest in companies in a wide range of industries, including the life sciences, biotech, IT, services, retail, Internet, financial, software, media, consumer products, and tech startups. TCA as a whole gives companies more than just capital; they also provide counsel, mentoring, and access to an extensive network of potential investors, customers, strategic partners, and management talent. Tech Coast Angels has been ranked by CB Insights to be among the Top 20 Angel Groups in the US; TCA was also ranked as #1 for Network Centrality, meaning we have more connections than anyone! If you are in the game-changing business, we are here to help.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Convertible Note, Funding Round
  • United States, Canada
Portfolio highlights
  • Reglagene — Reglagene is a therapeutics company that leverages its expertise in the design and development of brain penetrant medicines to create breakthrough therapies for the safe and effective treatment of brain diseases.
  • RealSeq Biosciences — RealSeq Biosciences’ core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction.
  • Trio Pharmaceuticals — Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.
Sante Ventures VC Fund · Austin, Texas, United States · 3 investments in the past 12 months
Privately Held Companies
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • United States, Canada, New Zealand
Portfolio highlights
  • BeeKeeperAI — BeeKeeperAI is a zero trust collaboration platform protecting both algorithm IP and regulated data.
  • Solu Therapeutics — Solu Therapeutics is a precision-medicine-focused company developing therapeutics to eliminate disease-driving cells.
  • Reprieve Cardiovascular — Reprieve Cardiovascular is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients.
Silicon Valley Bank VC Fund · Santa Clara, California, United States · 23 investments in the past 12 months
Silicon Valley Bank is the financial partner of the innovation economy; helping individuals and investors in the innovation ecosystem achieve extraordinary outcomes.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Debt Financing, Series B, Series A
  • United States, United Kingdom, Canada
Portfolio highlights
  • Carputty — Carputty is a superior way to finance a car. Buying new, used, or refinancing? Carputty's flexible line of credit simplifies the process. Get started now!
  • Coast — Coast is the simple, all-in-one fleet and fuel card that helps businesses easily pay for and track vehicle expenses. It's quick to set up, easy-to-use, and full of rewards.
  • HawkEye 360 — HawkEye 360 is a space-based RF data analytics company with one-of-a-kind solutions to better spectrum mapping and monitoring on land & water
Rev1 Ventures VC Fund · Columbus, Ohio, United States · 10 investments in the past 12 months
Rev1 Ventures provides seed stage venture capital funding in Columbus, Ohio along with startup services, space, mentoring, and connections. Learn more!
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Series A, Funding Round
  • United States, Germany
Portfolio highlights
  • Trace — Trace is the simplest way ever to create AR content and experiences for your product and business.
  • Champ — Through the application of its secure, patent-pending technology, CHAMPtitles ends the reliance on legacy systems to manage U.S. automobile titles. CHAMPtitles partners with each party in the vehicle title ecosystem to reduce their costs in handling titles, turning the burdensome administrative process of issuing a vehicle title into a profitableactivity.
  • Niobium Microsystems — Niobium Microsystems creates custom integrated circuit and microelectronic system solutions for clients with complex power, performance, and security constraints.
DeNovo Ventures VC Fund · Saratoga, California, United States
DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons learned from a history of successful investing and building successful companies. They believed that their unique combination of skills and perspectives could help entrepreneurs to build companies which would havesignificant clinical impact and generate superior returns. Seven years later, this belief continues to hold true, demonstrated by investment success in selected medical device and biotechnology companies. With $650 million under management, De Novo has made more than 40 investments in medical devices and biotechnology across three funds. They invest in all stages of enterprise development and growth – from early stage to late stage. The unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Series B, Series D, Series C
  • United States
Portfolio highlights
  • Avedro — Glaukos works relentlessly to create and deliver transformative therapies for patients struggling with glaucoma, corneal disorders, and retinal diseases.
  • Milo — Milo is a group action communicator, sophisticated wireless networking, audio processing & powerful hardware in a carefully crafted design.
  • Spinal Kinetics — The artificial disc replacement device from Orthofix is changing the lives of people suffering from spinal pain. Learn about this motion-saving product.
Shangbay Capital VC Fund · Palo Alto, California, United States · 5 investments in the past 12 months
ShangBay Capital is a venture capital company that brings best-in-class investments mainly in the U.S. medical devices technology, as well as biotech, and mobile healthcare sectors through early-stage venture equity participation
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Series A, Series B, Series D
  • United States, China, Canada
Portfolio highlights
  • Luminopia — Luminopia is the first FDA-approved binocular therapy for amblyopia.
  • Avation Medical — Avation Medical is pioneering new platforms for wearable nerve stimulation systems. They believe empowering patients to be in control of their therapies will allow for more personalized and custom care. That's why at Avation Medical, they are re‑imagining neuromodulation by developing patient‑centric solutions based on powerful, proven, smarttechnologies.Avation Medical transforms the neuromodulation market to elevate care for patients with chronic conditions.
  • Laplace Interventional — Laplace developing Transcatheter Tricuspid Valve Technology to offer an increase in life expectancy and an improvement to the quality of life to worldwide patients with tricuspid regurgitation.
Three Arch Partners VC Fund · Portola Valley, California, United States
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than 100 important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generatedstrong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series B, Series C, Funding Round
  • United States, Belgium
Portfolio highlights
  • Nevro — We Believe True Innovation Transforms More Lives
  • Neuronetics — Antidepressant medications don't work for everyone. If drugs haven't worked for you, learn about NeuroStar - safe, effective, lasting TMS therapy for depression.
  • Access Closure — Access Closure, Inc., a medical device company, provides access site management products to address the complex challenge of vascular closure during interventional and diagnostic procedures. The company's products include Mynx delivery system, a vascular closure device that seals the arteriotomy using a water-soluble and extravascular sealant,which expands in the tissue tract by absorbing blood and subcutaneous fluids. Access Closure, Inc. was founded in 2002 and is based in Mountain View, California.
Virginia Venture Partners VC Fund · Herndon, Virginia, United States · 7 investments in the past 12 months
Virginia Venture Partners is a family of seed-stage investment funds placing near-equity and equity investments in Virginia-based technology, life science, and cleantech companies. Virginia Venture Partners invests in companies with a high potential for achieving rapid growth and generating significant economic returns for entrepreneurs,co-investors, and the Commonwealth of Virginia. CIT’s family of funds includes:GAP Fund I is a vintage 2004 fund fully invested in a broad array of seed-stage technology companies. Portfolio.GAP BioLife Fund is a seed fund investing exclusively in life science companies.GAP Tech Fund is a seed fund investing in IT and technology companies.
Show more
Investment focus
  • Software, Health Care, SaaS
  • Seed, Funding Round, Series A
  • United States, Canada, France
Portfolio highlights
  • CarpeDM — CarpeDM app is an exclusive member-only dating community created for singles seeking meaningful relationships with professional Black women.
  • WRANGLD — WRANGLD operates as a SaaS company that provides a platform for the trades and service industries.
  • Bricklayer.ai — Bricklayer AI is the first automated AI security team. Run better, faster, more efficient security operations with AI agents alongside humans.
Green Park & Golf Ventures VC Fund · Dallas, Texas, United States
Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • United States, Israel, Sweden
Portfolio highlights
  • Validic — Meet the only EHR-integrated remote care solution delivering personalized care for clinicians and patients, making personal health data actionable.
  • Prolocor — Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
  • Worlds — Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before.
Third Rock Ventures VC Fund · Boston, Massachusetts, United States · 3 investments in the past 12 months
Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to patients.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States
Portfolio highlights
  • Rapport Therapeutics — Precision medicines to match the complexity of the human brain.
  • Seaport Therapeutics — Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
  • Synnovation Therapeutics — Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers. It is dedicated to the discovery and development of therapeutics that can improve the lives of people with cancer. Leveraging its deep expertise in medicinal chemistry, cancer biology, andpatient-focused precision medicine, it builds a diverse pipeline of novel small-molecule targeted therapies. It aims to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.
Morgenthaler Ventures VC Fund · Menlo Park, California, United States
Morgenthaler Ventures has been in the venture capital business for more than 45 years, steadily investing through every market cycle. Select past and present portfolio companies in the IT space include: Evernote, Lending Club, Siri, MuleSoft, Practice Fusion, Adara Media, Check, Doximity, PeopleMatter, Socrata, NuoDB, Jaspersoft, VoltageSecurity, Rhythm NewMedia, Nominum, Wize Commerce (NexTag) and back in the day, Apple.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Funding Round
  • United States, Canada, France
Portfolio highlights
  • Moximed — Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis.
  • SetPoint Medical — SetPoint Medical is pioneering bioelectronic medicine to develop a safe and cost-effective approach for treatment of chronic autoimmune diseases.
  • Relievant Medsystems — Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain.
St. Louis Arch Angels VC Fund · St Louis, Missouri, United States
The St. Louis Arch Angels is a network of accredited investors who fund early-stage businesses across the St. Louis region.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Series A, Funding Round
  • United States, Argentina
Portfolio highlights
  • Peptyde Bio — Peptyde Bio is an Agtech startup positioned to become the go-to supplier of new AMPs.
  • SentiAR — SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.
  • Impetus Agriculture — Impetus Agriculture focuses on developing multiple topical or transgenic insect control products. Products that are safe, effective, and sustainable. Products that are not subject to the same insect resistance that has developed in current commercial products.
Life Science Angels VC Fund · Sunnyvale, California, United States
Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Funding Round, Seed, Series A
  • United States, Israel, The Netherlands
Portfolio highlights
  • InnoSIGN — We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.
  • Allyx Therapeutics — Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies designed to reverse neurodegeneration. Allyx Therapeutics' product is an orally bioavailable small molecule that acts as a silent allosteric modulator, enabling clinicians to get a drug that is capable of delivering a disease-modifying approach and preservecognition in patients.
  • Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
Keiretsu Capital VC Fund · Seattle, Washington, United States · 3 investments in the past 12 months
Keiretsu Capital LLC is an affiliate of the World's Leading Angel Network, Keiretsu Forum, and manages funds which enable limited partners to co-invest in the proprietary deal flow of the angel investors.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Funding Round, Series A, Seed
  • United States, Canada, India
Portfolio highlights
  • Clensta — Clensta is a biotechnology start-up to improve the National Hygiene condition whilst addressing the aspect of water conservation. Clensta is an Indian startup and in association with IIT Delhi, works to create innovative healthcare solutions to make hygiene accessible for anyone, anytime, and anywhere. Driven by their aim to create products thatpromote complete cleaning solutions without water.
  • Healionics — Healionics has applied its expertise in synthetic biomaterials to develop a novel vascular graft (artificial blood vessel) that, unlike existing grafts, remains open to blood flow long-term without need for costly interventions. Its first commercial application will be as a more reliable means of vascular access for dialysis patients, with asubsequent application to treat peripheral artery disease. We have great results in multiple controlled animal studies, a large patent portfolio, established production capacity, and are ready to begin human studies later this year in preparation for market launch.Near-Term Problem / Market Opportunity: Vascular Access for Dialysis Kidney failure patients need to have their blood filtered 3 times per week via dialysis. This removes waste from the blood, which would otherwise cause them to die. However, current methods for repeatedly accessing the bloodstream for dialysis are unreliable. This problem is a huge contributor to the $50 billion per year that the U.S. spends on dialysis patients (7% of Medicare’s entire budget!). A vascular graft is often implanted under the skin (connecting an artery to a vein) to create an access site with sufficient bloodflow for dialysis -- but existing grafts tend to occlude quickly, requiring repeated expensive interventions to keep them open.Solution: STARgraft Because our vascular graft remains open to blood flow much longer than existing grafts, it can potentially satisfy a severe unmet clinical need for ready-to-use, safe, long-term dialysis access, while substantially reducing costs, illness and death rate among dialysis patients.Product Pipeline We have additional products in development, including an implantable port which will allow needle-free dialysis. Eliminating the use of needles would further reduce cost and illness among dialysis patients, and allow them to perform dialysis in the convenience of their own home. In addition, our platform STAR biomaterial can improve the performance of a wide range of implantable devices via its remarkable ability to prevent both infection and scar tissue. We currently have two corporate-funded development contracts to explore STAR material’s use in multiple other device applications.
  • Another Tomorrow — Conscious Clothing. Education. Action. Another Tomorrow pushes the boundaries of what responsibly grown, and ethically manufactured materials can achieve. Sensual and strong, our collection is designed for living.
Square 1 Bank VC Fund · Durham, North Carolina, United States
Square 1 Bank is a full service commercial bank dedicated exclusively to serving the financial needs of the venture capital community and entrepreneurs in all stages of growth and expansion. Square 1's expertise, focus and strong capital base provide solid support for its clients' needs. The bank offers tailored products and solutionsaided by the latest in technological innovations. To serve its relationships, Square 1 has offices coast to coast in Austin, Boston, DC, Denver, Durham, New York, San Diego, Santa Monica, Seattle, and Silicon Valley.
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Debt Financing, Post-IPO Debt, Funding Round
  • United States, Israel
Portfolio highlights
  • CallRail — CallRail is a phone call tracking and analytics platform businesses use to understand which marketing campaigns drive leads and conversions. Its intuitive software helps data-driven marketers optimize the performance of their online and offline advertising campaigns, increase sales effectiveness, and improve customer retention.
  • ScienceLogic — Empower your IT staff & propel your digital transformation with ScienceLogic's AIOps and IT infrastructure monitoring platform.
  • ShopKeep — Everything ShopKeep does supports growing and independent businesses. Built by and for small business owners, ShopKeep provides an intuitive, secure, iPad point-of-sale system with POS software that empowers merchants to run smarter businesses by optimizing staffing, managing inventory and accessing real time sales reports and customer informationon one seamless, cloud-based platform. With more than 25,000 customers, ShopKeep’s award-winning customer care team is available to help 24/7 and provides a robust support network for growing business owners. ShopKeep is headquartered in New York City, with offices in Portland (OR), Chicago (IL), and Belfast (NIR).
Golden Seeds VC Fund · New York, New York, United States · 2 investments in the past 12 months
Golden Seeds is a seed-stage investment firm with a focus on women leaders. Their investment thesis rests on the extensive research that concludes that gender-diverse teams produce a better return on equity. By seeking companies where women hold leadership positions and own substantial equity, they are funding companies that are likely to havediverse perspectives that will contribute to success.
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Series A, Seed, Series B
  • United States, Canada
Portfolio highlights
  • Nalu Bio — Nalu Bio is the leading innovator in the discovery and production of next generation cannabinoid ingredients.
  • EliseAI — Elise is an artificially intelligent leasing agent for multifamily communities. As an AI leasing assistant, Elise responds, follows up, and books showing appointments.
  • Jurata Thin Film — Revolutionizing the manufacturing, storage, and delivery of vaccines and biologics
Launch NY VC Fund · Buffalo, New York, United States · 4 investments in the past 12 months
Launch NY is a nonprofit venture development organization in Upstate New York. We provide pro bono mentoring and access to risk capital for high-growth startups.Are you ready to launch?Check out our NEW Resource Navigator under the "Entrepreneurs" tab for the most up-to-date opportunities for entrepreneurs! Apply Now Invest Now Donate Now Entrepreneurs Launch Your
Show more
Investment focus
  • Health Care, Software, Food and Beverage
  • Convertible Note, Seed, Pre-Seed
  • United States, Canada
Portfolio highlights
  • Telesafety — TeleSafety is a mobile app that provides real-time access to workplace safety experts by helping with important questions or professional advice.
  • Caretech Human — Automated solution for continuous health monitoring and diseases prevention
  • Diadem Capital — Diadem Capital is a curated marketplace for venture debt and venture capital. Connecting founders with venture capital funds, family offices, & corporate VCs.
Investors by industry
Investors by country
Investors in United States by industry